From Nasdaq: 2025-04-25 18:15:00

Teladoc (TDOC) closed at $7.20, down -0.83% from the previous day, trailing the S&P 500 and Dow but behind Nasdaq. Shares fell 15.19% in the last month, underperforming the Medical sector and S&P 500.

Teladoc’s upcoming earnings report on April 30, 2025, projects earnings of -$0.33 per share with a revenue of $617.67 million. Analyst estimates predict -$0.88 EPS and $2.51 billion revenue for the fiscal year.

With a Zacks Rank #3 (Hold), Teladoc’s industry ranks in the top 35%. Zacks Industry Rank of 86 shows strong performance. Follow stock-moving metrics on Zacks.com for updates.

Zacks offers access to all picks for $1, no obligation. Explore services like Surprise Trader, Stocks Under $10, and more. Thousands have benefited from Zacks’ portfolio services, like closing 256 positions with double- and triple-digit gains in 2024.

Find the latest stock recommendations from Zacks Investment Research and get a free stock analysis report of Teladoc Health, Inc. Read more on Zacks.com for in-depth analysis and insights into Teladoc’s stock performance.



Read more at Nasdaq: Teladoc (TDOC) Stock Sinks As Market Gains: Here’s Why